Press Releases

May 28, 2024

Lucy Therapeutics Secures New Funding to Advance New Alzheimer’s and Parkinson’s Treatments

Visit Link

October 11, 2023

Lucy Therapeutics Expands Cutting-Edge Medical Research Program - New Grant Supports Development of Novel Mitochondrial-based Treatments for Rett syndrome

Visit Link

October 13, 2022

Lucy Therapeutics Debuts Novel Therapeutic Agents for Parkinson’s Disease at Michael J. Fox Foundation Annual Conference

Visit Link

April 11, 2022

Lucy Therapeutics Receives $4.9 Million Grant from Michael J. Fox Foundation

Visit Link

In the News

July 19, 2023

Back of the Napkin

Podcast: Dr. Amy Ripka talks about her nonlinear path to founding Lucy Therapeutics, the fabled "ah-ha moment" when it comes to ideas, and how having various interests has been transformative for her in approaching challenges from new angles.

Visit Link

March 8, 2023


Podcast: How a 3.2-million-year-old fossil inspired the CEO to unlock the mysteries of mitochondrial dysfunction.

Visit Link

January 3, 2023

Cultivating Greatness

Podcast: Dr. Amy Ripka, Founder/CEO of Lucy Therapeutics, shares her amazing story of driving disruptive innovation in the biotech industry. She describes her scientific "curiosity" that led to the formulation of her disruptive idea, and the gutsy "courage" that drove her to found Lucy Therapeutics against all odds, overcoming the industry's significant resistance.

Visit Link

December 14, 2022


Lucy: mitochondrial solutions to CNS diseases. Lucy Therapeutics views mitochondrial dysfunction as a common and core driver of many CNS diseases, and aims to build a pipeline of programs against “rate-limiting” targets that gate the progression of that dysfunction.

Visit Link

December 7, 2022

Longevity Technology

Do mitochondria hold the key to a Parkinson’s breakthrough? Lucy Therapeutics founder on mitochondria, Parkinson’s and the importance of hypothesis-driven research and development.

Visit Link

November 19, 2022

Cultivating Greatness

Podcast: A creative conversation with Dr. Amy Ripka, Founder/CEO of Lucy Therapeutics and professional violinist, about how she leverages the principles of performing music to her own leadership practice.

Visit Link

September 12, 2022

Clinical Leader

Beyond Nuclear Genetics: Let's Think Differently About CNS Disease Targets.

Visit Link

June 27, 2022

Lab Central

Pride Q+A with Dr. Amy Ripka, CEO and Founder at Lucy Therapeutics

Visit Link

February 11, 2021

ACS Boss Talk

Dr. Amy Ripka has over 30 issued patents and has been involved in multiple INDs in different therapeutic areas. She has deep connections in the medicinal chemistry community with long-time service to the ACS MEDI Executive Committee and was the elected Chair of the 2012 Medicinal Chemistry Gordon Research Conference.

Visit Link

September 16, 2020

University of Wisconsin-Madison News

A Rich History of Research and Mentorship

Visit Link